Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on October 22, 2026

Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs
BioNTech treibt klinische Phase-3-Studie zu Pumitamig mit Gileads gegen TROP2-gerichtetem Antikörper-Wirkstoff-Konjugat Sacituzumab Govitecan bei Dreifach-Negativem Brustkrebs voran
BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead’s TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer
Aveanna Announces Third Quarter 2026 Earnings Release Date and Conference Call
Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026
Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies
Rakovina Therapeutics and Variational AI Advance Brain-Penetrant ATR Program Toward Development Candidate Selection
KFSH Expands Capacity for Complex Care by Redesigning the Emergency Patient Journey
Levicept Announces Attendance at Major Healthcare Conferences in Q4
Nxera Pharma Submits Marketing Authorization Application for Vamorolone in South Korea for the Treatment of Duchenne Muscular Dystrophy
Persica Pharmaceuticals presents antibiotic exposure-response analysis at the International Society of Pain & Neuroscience (ISPN) Annual Conference
Oculis Reports New Phase 2 ACUITY Biomarker Data Further Supporting Privosegtor’s Neuroprotective Potential in Optic Neuritis
Ipsen delivers outstanding sales growth in the first nine months of 2026 and further upgrades its full-year guidance
Ipsen réalise une croissance remarquable des ventes au cours des neuf premiers mois de 2026 et relève à nouveau ses prévisions pour l’exercice en cours
Pharming Group announces third quarter 2026 revenues above market expectations
argenx Reports Third Quarter 2026 Financial Results and Provides Business Update
Molecular Partners Nominates MP0730 as Next Candidate in Expanding Pipeline of Radiotherapeutics, Targeting CD70
Neue im JAHA veröffentlichte EggNest®-Studie und texanische Ausnahmegenehmigung bestätigen den Wandel hin zu Arbeitsabläufen ohne Bleischürzen im interventionellen Labor
Nuevo estudio de EggNest® publicado en JAHA y autorización regulatoria en Texas validan la transición hacia flujos de trabajo sin delantal plomado en los laboratorios de intervencionismo
Une nouvelle étude sur EggNest® publiée dans JAHA et une dérogation réglementaire au Texas confirment l’évolution vers des procédures sans tablier plombé en salle de cardiologie interventionnelle

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Healthcare Industry Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.